Pi3k and P110delta Hyperactivation Syndrome
📧 Sign up to get email alerts when something new happens for Pi3k and P110delta Hyperactivation Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: CVL237 Tablets for APDS/PASLI [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update for CVL237 tablets in PI3K and P110delta hyperactivation syndrome (APDS/PASLI). Status not specified.